Europe PMCopen access
Rewiring mTOR signaling in Alzheimer's disease: emerging mTOR modulators beyond oncology
Inhibitors, Cancer, Alzheimers disease, Neurodegeneration, PI3K/Akt pathway, Mechanistic Target Of Rapamycin
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 273312
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.